WHO identified record keeping as key to reducing the risks of hepatitis. Read more about WHO identified record keeping as key to reducing the risks of hepatitis.
People with a bleeding disorder who were treated with UK-sourced pooled factor concentrates or antithrombin between 1980 and 2001 were considered at risk of vCJD and informed by their haemophilia centre. Read more about People with a bleeding disorder who were treated with UK-sourced pooled factor concentrates or antithrombin between 1980 and 2001 were considered at risk of vCJD and informed by their haemophilia centre.
The second case of transfusion-related vCJD was reported. Read more about The second case of transfusion-related vCJD was reported.
The Government announced the exclusion of blood donors who had received transfusions of whole blood components since January 1980. Read more about The Government announced the exclusion of blood donors who had received transfusions of whole blood components since January 1980.
The death of a patient thought to have been infected with vCJD through transfusion was announced. 15 individuals who received donations of blood from donors who subsequently developed vCJD were to be notified by the Health Protection Agency. Read more about The death of a patient thought to have been infected with vCJD through transfusion was announced. 15 individuals who received donations of blood from donors who subsequently developed vCJD were to be notified by the Health Protection Agency.
The Department of Health purchased the largest remaining independent US plasma collector, Life Resources Incorporated, to ensure the continuity of supply without needing to rely on UK-sourced plasma. Read more about The Department of Health purchased the largest remaining independent US plasma collector, Life Resources Incorporated, to ensure the continuity of supply without needing to rely on UK-sourced plasma.
The Government announced financial support packages for victims of vCJD. Read more about The Government announced financial support packages for victims of vCJD.
The Government announced a programme to phase out the use of UK-sourced plasma in the manufacture of blood products. Read more about The Government announced a programme to phase out the use of UK-sourced plasma in the manufacture of blood products.